Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cellectricon’s new neuroinflammation discovery services offer advanced insight into chronic pain
Cellectricon will grant Clients long-term partnerships focusing on the development of novel in vitro models to better understand…
Cipla receives final approval for generic version of Migranal with a Competitive Generic Therapy…
Cipla is the “first approved applicant” for such CGT and, is therefore, eligible for 180 days of CGT exclusivity which will begin…
Strides Pharma Q4 results: Posts net loss of Rs 206.57 crore
The company's consolidated revenue from operations stood at Rs 618.64 crore for the quarter under consideration. It was Rs 616.18…
Global regulators commit to cooperate on observational research during COVID-19 pandemic
At the second workshop on observational studies of real-world data generated during clinical practice in the context of COVID-19,…
Industry seeks clarity in regulations for sale of hand sanitisers
Opposing views prevail on the inclusion of hand sanitisers under Schedule K of Drugs and Cosmetics Rules, 1945
Oxford Immunotec releases the T-SPOT Discovery SARS-CoV-2 kit for COVID-19 research
This research kit could make a significant contribution towards development of a new tool to manage the COVID-19 pandemic, which…
Bharat Biotech, Thomas Jefferson University collaborate on COVID-19 vaccine candidate
The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known…
Govt nod for manufacture of COVID-19 vaccine before clinical trials end will expedite access:…
Though certain rules have been deferred by the Government in the public interest to meet the emergent situation that has arisen…
Early data on Moderna’s COVID-19 vaccine insufficient: Stat News
Moderna said the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group…
Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials
The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether…